Literature DB >> 31928886

GDF15 Induces Anorexia through Nausea and Emesis.

Tito Borner1, Evan D Shaulson1, Misgana Y Ghidewon2, Amanda B Barnett1, Charles C Horn3, Robert P Doyle4, Harvey J Grill5, Matthew R Hayes6, Bart C De Jonghe7.   

Abstract

Growth differentiation factor 15 (GDF15) is a cytokine that reduces food intake through activation of hindbrain GFRAL-RET receptors and has become a keen target of interest for anti-obesity therapies. Elevated endogenous GDF15 is associated with energy balance disturbances, cancer progression, chemotherapy-induced anorexia, and morning sickness. We hypothesized that GDF15 causes emesis and that its anorectic effects are related to this function. Here, we examined feeding and emesis and/or emetic-like behaviors in three different mammalian laboratory species to help elucidate the role of GDF15 in these behaviors. Data show that GDF15 causes emesis in Suncus murinus (musk shrews) and induces behaviors indicative of nausea/malaise (e.g., anorexia and pica) in non-emetic species, including mice and lean or obese rats. We also present data in mice suggesting that GDF15 contributes to chemotherapy-induced malaise. Together, these results indicate that GDF15 triggers anorexia through the induction of nausea and/or by engaging emetic neurocircuitry.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  GDF15; GFRAL; MIC-1; Suncus murinus; anorexia; chemotherapy; emesis; malaise; nausea; obesity

Mesh:

Substances:

Year:  2020        PMID: 31928886      PMCID: PMC7161938          DOI: 10.1016/j.cmet.2019.12.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  63 in total

1.  Excitatory Hindbrain-Forebrain Communication Is Required for Cisplatin-Induced Anorexia and Weight Loss.

Authors:  Amber L Alhadeff; Ruby A Holland; Huiyuan Zheng; Linda Rinaman; Harvey J Grill; Bart C De Jonghe
Journal:  J Neurosci       Date:  2017-01-11       Impact factor: 6.167

2.  A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.

Authors:  Elizabeth G Mietlicki-Baase; Claudia G Liberini; Jayme L Workinger; Ron L Bonaccorso; Tito Borner; David J Reiner; Kieran Koch-Laskowski; Lauren E McGrath; Rinzin Lhamo; Lauren M Stein; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle; Matthew R Hayes
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

3.  Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer.

Authors:  Anne Cathrine Staff; Annika J Bock; Caroline Becker; Tibor Kempf; Kai C Wollert; Ben Davidson
Journal:  Gynecol Oncol       Date:  2010-06-23       Impact factor: 5.482

Review 4.  Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model.

Authors:  Yingze Wang; L V Juan; Xiaowei Ma; Dongliang Wang; Huili Ma; Yanzhong Chang; Guangjun Nie; Lee Jia; Xianglin Duan; Xing-Jie Liang
Journal:  Curr Drug Metab       Date:  2010-07       Impact factor: 3.731

5.  Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation.

Authors:  Matthew R Hayes; Theresa M Leichner; Shiru Zhao; Grace S Lee; Amy Chowansky; Derek Zimmer; Bart C De Jonghe; Scott E Kanoski; Harvey J Grill; Kendra K Bence
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

6.  Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.

Authors:  Lorenzo Cohen; Carl A de Moor; Peter Eisenberg; Eileen E Ming; Henry Hu
Journal:  Support Care Cancer       Date:  2006-11-14       Impact factor: 3.603

Review 7.  MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation.

Authors:  W D Fairlie; A G Moore; A R Bauskin; P K Russell; H P Zhang; S N Breit
Journal:  J Leukoc Biol       Date:  1999-01       Impact factor: 4.962

8.  Unfolding the mechanism of cisplatin induced pathophysiology in spleen and its amelioration by carnosine.

Authors:  Sharmistha Banerjee; Krishnendu Sinha; Sayantani Chowdhury; Parames C Sil
Journal:  Chem Biol Interact       Date:  2017-11-27       Impact factor: 5.192

Review 9.  The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.

Authors:  Vicky W W Tsai; Yasmin Husaini; Amanda Sainsbury; David A Brown; Samuel N Breit
Journal:  Cell Metab       Date:  2018-09-04       Impact factor: 27.287

10.  Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew).

Authors:  John A Rudd; Sze W Chan; Man P Ngan; Longlong Tu; Zengbing Lu; Claudio Giuliano; Emanuela Lovati; Claudio Pietra
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

View more
  46 in total

1.  GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss.

Authors:  Tito Borner; Hallie S Wald; Misgana Y Ghidewon; Bei Zhang; Zhidan Wu; Bart C De Jonghe; Danna Breen; Harvey J Grill
Journal:  Cell Rep       Date:  2020-04-21       Impact factor: 9.423

2.  Advances in GDF15 research.

Authors:  Alan Morris
Journal:  Nat Rev Endocrinol       Date:  2020-03       Impact factor: 43.330

Review 3.  GDF15: a potential therapeutic target for type 1 diabetes.

Authors:  Soumyadeep Sarkar; John T Melchior; Hayden R Henry; Farooq Syed; Raghavendra G Mirmira; Ernesto S Nakayasu; Thomas O Metz
Journal:  Expert Opin Ther Targets       Date:  2022-02-09       Impact factor: 6.902

4.  A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models.

Authors:  Tito Borner; Evan D Shaulson; Ian C Tinsley; Lauren M Stein; Charles C Horn; Matthew R Hayes; Robert P Doyle; Bart C De Jonghe
Journal:  Diabetes Obes Metab       Date:  2020-06-25       Impact factor: 6.577

Review 5.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

6.  GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.

Authors:  Tito Borner; Caroline E Geisler; Samantha M Fortin; Richard Cosgrove; Jorge Alsina-Fernandez; Mridula Dogra; Sarah Doebley; Marcos J Sanchez-Navarro; Rosa M Leon; Jane Gaisinsky; Arianna White; Ankur Bamezai; Misgana Y Ghidewon; Harvey J Grill; Richard C Crist; Benjamin C Reiner; Minrong Ai; Ricardo J Samms; Bart C De Jonghe; Matthew R Hayes
Journal:  Diabetes       Date:  2021-08-11       Impact factor: 9.461

Review 7.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

8.  GFRAL-expressing neurons suppress food intake via aversive pathways.

Authors:  Paul V Sabatini; Henriette Frikke-Schmidt; Joe Arthurs; Desiree Gordian; Anita Patel; Alan C Rupp; Jessica M Adams; Jine Wang; Sebastian Beck Jørgensen; David P Olson; Richard D Palmiter; Martin G Myers; Randy J Seeley
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

9.  Area Postrema Cell Types that Mediate Nausea-Associated Behaviors.

Authors:  Chuchu Zhang; Judith A Kaye; Zerong Cai; Yandan Wang; Sara L Prescott; Stephen D Liberles
Journal:  Neuron       Date:  2020-12-04       Impact factor: 17.173

Review 10.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.